Current location:Home > Pharmaceutical

(4R,6R,7E,10Z)-2,3,3aβ,4,5,6,9,11aα-Octahydro-3-methylene-6-hydroxy-2,9-dioxo-4-(2-methylpropanoyloxy)-6,10-dimethylcyclodeca[b]furan

  • CAS No.: 59979-56-5
  • Purity: 99%
inquiry

Manufacturers supply cost-effective and customizable (4R,6R,7E,10Z)-2,3,3aβ,4,5,6,9,11aα-Octahydro-3-methylene-6-hydroxy-2,9-dioxo-4-(2-methylpropanoyloxy)-6,10-dimethylcyclodeca[b]furan 59979-56-5

  • Molecular Formula: C19H24O6
  • Molecular Weight: 348.396
  • Vapor Pressure: 1.8E-13mmHg at 25°C 
  • Boiling Point: 530.5°Cat760mmHg 
  • Flash Point: 186.9°C 
  • PSA: 89.90000 
  • Density: 1.2g/cm3 
  • LogP: 1.87830 

(4R,6R,7E,10Z)-2,3,3aβ,4,5,6,9,11aα-Octahydro-3-methylene-6-hydroxy-2,9-dioxo-4-(2-methylpropanoyloxy)-6,10-dimethylcyclodeca[b]furan(Cas 59979-56-5) Usage

General Description

The chemical compound "(4R,6R,7E,10Z)-2,3,3aβ,4,5,6,9,11aα-Octahydro-3-methylene-6-hydroxy-2,9-dioxo-4-(2-methylpropanoyloxy)-6,10-dimethylcyclodeca[b]furan" is a complex molecule with a cyclodeca[b]furan ring structure. It contains a 3-methylene group, a 6-hydroxy group, and a 2,9-dioxo functional group. It also has a 2-methylpropanoyloxy substitution. The stereochemistry of the compound includes four chiral centers at the 4, 6, 7, and 11a positions, which are designated as (4R,6R,7E,10Z). (4R,6R,7E,10Z)-2,3,3aβ,4,5,6,9,11aα-Octahydro-3-methylene-6-hydroxy-2,9-dioxo-4-(2-methylpropanoyloxy)-6,10-dimethylcyclodeca[b]furan likely has a range of potential pharmaceutical applications due to its unique structure and functional groups, but further research would be needed to determine its specific properties and potential uses.

InChI:InChI=1/C19H24O6/c1-10(2)17(21)25-15-9-19(5,23)7-6-13(20)11(3)8-14-16(15)12(4)18(22)24-14/h6-8,10,14-16,23H,4,9H2,1-3,5H3/b7-6-,11-8-/t14-,15-,16+,19+/m1/s1

59979-56-5 Relevant articles

Stereochemistry of Ciliarin, Zexbrevin, and Their Relatives

Chowdhury, Pratish K.,Sharma, Ram P.,Thyagarajan, Gopalakrishna,Herz, Werner,Govindan, Serengolam V.

, p. 4993 - 4997 (2007/10/02)

-

59979-56-5 Process route

orizabin
34367-14-1

orizabin

tagitinin-C
59979-56-5

tagitinin-C

Conditions
Conditions Yield
With sodium acetate; acetic anhydride; at 100 ℃; for 0.5h;
70%
Isobutyric acid (Z)-(1R,2R,4R,11R)-4-hydroxy-4,9-dimethyl-14-methylene-8,13-dioxo-6,12-dioxa-tricyclo[9.3.0.0<sup>5,7</sup>]tetradec-9-en-2-yl ester
75197-73-8,75247-16-4

Isobutyric acid (Z)-(1R,2R,4R,11R)-4-hydroxy-4,9-dimethyl-14-methylene-8,13-dioxo-6,12-dioxa-tricyclo[9.3.0.05,7 ]tetradec-9-en-2-yl ester

tagitinin-C
59979-56-5

tagitinin-C

Conditions
Conditions Yield
Multi-step reaction with 2 steps
1: aq. AcOH, Zn / 1 h / 100 °C
2: 70 percent / sodium acetate, acetic anhydride / 0.5 h / 100 °C
With sodium acetate; acetic anhydride; acetic acid; zinc;

59979-56-5 Upstream products

  • 34367-14-1
    34367-14-1

    orizabin

  • 75197-73-8
    75197-73-8

    Isobutyric acid (Z)-(1R,2R,4R,11R)-4-hydroxy-4,9-dimethyl-14-methylene-8,13-dioxo-6,12-dioxa-tricyclo[9.3.0.05,7 ]tetradec-9-en-2-yl ester

59979-56-5 Downstream products

  • 59979-58-7
    59979-58-7

    tagitinin E

  • 59979-57-6
    59979-57-6

    tagitinin F

*Product Name
CasNo
Purity
Quantity
Company name
*Email
*Other Description
*Verification code:
Submit
Purchase Posted Successfully, our staff will contact you within 24 hours.